ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,646.67
1.04%
Dow Jones
44,735.74
0.05%
Gold vs US Dollar
2,795.615
1.28%
Brent Oil
76.17
0.33%
Bitcoin
105,711.43
1.90%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. AstraZeneca PLC (AZN) Share Price

AZN AstraZeneca PLC

70.74
0.49 (0.70%)
Last Updated: 16:00:14
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 AstraZeneca PLC NASDAQ:AZN NASDAQ Depository Receipt  ADS Rep One Half Ordinary Share
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.49 0.70 70.74 70.74 70.75 70.80 70.32 70.42 1,545,139 16:00:14   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 45.81B 5.96B 1.9203 58.73 217.85B
 Type  Size  Price  Time  Units 
 9 2 70.7436 16:00:19 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AZN News
30/01/202510:45PRNUSAZN LAWSUIT ALERT: The Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline
27/01/202523:00BWENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
27/01/202510:45PRNUSShareholders of AstraZeneca PLC Should Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights - AZN
23/01/202519:33PRNCAAstraZeneca prévoit un investissement de 820 M$ CA (570 M$ US) au Canada pour consolider son statut grandissant de plaque tournante mondiale et faire progresser la réalisation d'essais cliniques
23/01/202519:32PRNCAAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
23/01/202510:45PRNUSAstraZeneca PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights - AZN
23/01/202510:00PRNUSAstraZeneca PLC Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AZN
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
26/01/202518:43PBBAstraZeneca6,242
25/04/202407:41PBBAlzheimer's can be caught .... It's a transmissible disease127
02/11/202114:29PBBASTRAZENECA, MSD PROSTATE CANCER DRUG GETS CHINA GREEN LIGHT3
20/09/202114:45PBBINDIA'S COVID DEATH RATE IS 278 PER 1 MILLION..UK'S IS 1876..THINK ABOUT IT2
15/09/202111:17PBBEu3
03/09/202115:44PBBEU and AZN 4
25/05/202114:17PBBAlexion deal8
22/05/202114:47PBBAzn Japan1
12/05/202111:28PBBExecutive pay2
05/05/202114:04PBBVoting agst Deal1
Data Downloads for AZN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest AstraZeneca PLC Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads